PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Clinique partners with Icahn School of Medicine at Mount Sinai to establish the Mount Sinai-Clinique Healthy Skin Dermatology Center

New research center aims to deliver breakthrough advancements in dermatology and discover solutions for healthy and allergic skin

Clinique partners with Icahn School of Medicine at Mount Sinai to establish the Mount Sinai-Clinique Healthy Skin Dermatology Center
2024-02-02
(Press-News.org)

New York, NY (February 2, 2024) – Clinique and Icahn School of Medicine at Mount Sinai today announced a philanthropic partnership to establish the Mount Sinai-Clinique Healthy Skin Dermatology Center. The Center will develop forward-thinking research in dermatology, exploring the biological underpinnings of how skin ages, skin allergies and inflammatory or eczematous skin conditions, including eczema (or atopic dermatitis) and contact dermatitis. Rooted in a shared mission to conduct dermatological research that improves patients’ lives, the partnership will focus on applicable scientific discovery and leading-edge innovation to modernize allergy science in order to identify innovative solutions for these skin conditions.

Research conducted under the Mount Sinai-Clinique Healthy Skin Dermatology Center aims to uncover scientific findings to accelerate the creation of new topical and systemic treatments that help alleviate allergic skin conditions. The priority is to bridge basic science with practical application in the clinic to improve people’s lives through healthy skin. By investigating healthy skin, along with the skin of those with atopic dermatitis and other allergic skin disorders, the researchers may learn how to significantly slow the visible signs of aging in all people as well as in patients with eczema, who show signs of premature or accelerated aging. Insights from this research aim to spur advances in the field of dermatology and skin health. Additionally, they will inform and inspire Clinique in future product innovation to offer further solutions for people with allergic or sensitive skin.

“As a brand that has offered dermatologist guided solutions and allergy tested solutions since its inception, Clinique is proud to partner with the renowned institution of Icahn Mount Sinai and its team of physician-scientists, led by a world-renowned expert in allergic and inflammatory skin diseases, Dr. Emma Guttman. We are inspired by the team’s dedication to the research and future discoveries of allergic skin and its life impact, including aging. We are energized by our mutual commitment and steadfast belief that great skin can be created and maintained for all. I am confident that this first-of-its-kind partnership will enable groundbreaking research by leading physician-scientists dedicated to advancing allergy science,” Michelle Freyre, President, Global Brands, Clinique.

Dr. Emma Guttman, MD, PhD, Waldman Professor and System Chair, Department of Dermatology at the Icahn School of Medicine, a trailblazer in dermatologic science, has dedicated her career to bridging science with practice intended to improve patients’ lives. Her work has led to novel therapeutic targets for patients suffering from inflammatory skin conditions. Drawing inspiration from her personal and family history of eczema and other allergic conditions, Dr. Guttman has made it her mission to alleviate sensitive skin.

“Years of chronic inflamed skin plays a role in premature aging. Extensive research has helped us understand the molecular map of skin conditions associated with allergy such as eczema and contact dermatitis, and we’re now at a pivotal point in addressing these conditions and more. With Clinique’s support, we will continue to actively explore targeted approaches to reversing eczematous and allergic skin conditions with the goal of creating and sustaining healthy skin. In turn, we want to use this understanding to address and prevent the process of age-related inflammation or ‘inflammaging’ in the first place,” says Dr. Guttman, who also directs the Center of Excellence in Eczema at Mount Sinai and the Laboratory of Inflammatory Skin Diseases at Icahn Mount Sinai.

The laboratory of Inflammatory Skin Diseases at Icahn Mount Sinai has a major focus on atopic dermatitis, contact dermatitis, alopecia areata, and other inflammatory skin diseases. It has made paradigm-shifting discoveries on the immunologic basis of atopic dermatitis, opening the door to new therapeutics. Dr. Guttman’s lab developed the only comprehensive molecular maps of atopic dermatitis, defining skin differentiation and immune-circuits characterizing this disease across phenotypes and ages. This work on atopic dermatitis/eczema has contributed directly to many of the recently developed treatments for this disease, earning Dr. Guttman and her lab a unique place as being a top leader in dermatology and immunology worldwide.

Clinique has a long-standing history of partnering with dermatologists, including its Founding Dermatologist, Norman Orentreich, MD, and incorporating patients’ insights in its innovation since 1968. His children, Catherine Orentreich, MD, and David Orentreich, MD, the brand’s Guiding Dermatologists, continue their father’s legacy for Clinique. Dr. David Orentreich is Assistant Clinical Professor of Dermatology at Icahn Mount Sinai, and he and Dr. Catherine Orentreich are members of the Mount Sinai Dermatology Advisory Board.

In this meaningful mission, Clinique has made a philanthropic commitment of $5 million over seven years for the advancement and evolution of allergy science through the partnership and founding of the Mount Sinai-Clinique Healthy Skin Dermatology Center. The funds will be used to recruit the best and brightest physicians and scientists, and provide resources for the most advanced equipment, clinical and laboratory space, and key support staff. The studies conducted by the Mount Sinai-Clinique Healthy Skin Dermatology Center will include all ages, genders, races and ethnicities, and will also investigate the effects of factors such as diet, exercise, and stress on the skin of healthy people. Mount Sinai predicts that with Clinique’s support, critical breakthroughs will be fast-tracked, from the earliest stages of the multiyear partnership.

 

+++

 

About Mount Sinai Health System:

Mount Sinai Health System is one of the largest academic medical systems in the New York metro area, with more than 43,000 employees working across eight hospitals, more than 400 outpatient practices, more than 300 labs, a school of nursing, and a leading school of medicine and graduate education. Mount Sinai advances health for all people, everywhere, by taking on the most complex health care challenges of our time—discovering and applying new scientific learning and knowledge; developing safer, more effective treatments; educating the next generation of medical leaders and innovators; and supporting local communities by delivering high-quality care to all who need it. Through the integration of its hospitals, labs, and schools, Mount Sinai offers comprehensive health care solutions from birth through geriatrics, leveraging innovative approaches such as artificial intelligence and informatics while keeping patients’ medical and emotional needs at the center of all treatment. The Health System includes approximately 7,400 primary and specialty care physicians; 13 joint-venture outpatient surgery centers throughout the five boroughs of New York City, Westchester, Long Island, and Florida; and more than 30 affiliated community health centers. Hospitals within the System are consistently ranked by Newsweek’s® “The World’s Best Smart Hospitals, Best in State Hospitals, World Best Hospitals and Best Specialty Hospitals” and by U.S. News & World Report's® “Best Hospitals” and “Best Children’s Hospitals.” The Mount Sinai Hospital is on the U.S. News & World Report® “Best Hospitals” Honor Roll for 2023-2024.

About Clinique:

In 1968, a beauty editor asked a leading New York City dermatologist, “Can great skin be created?” The answer: yes.  And with that yes, Clinique was born. Today Clinique is the #1 Dermatologist Brand in Skincare in the US* and #1 Dermatologist Brand in Makeup in the US**, offering its dermatologist guided, allergy tested solutions for remarkable skin results. The brand is sold in 107 markets worldwide. Clinique’s clinical solutions are informed by years of research, working with dermatologists, scientists, and ophthalmologists. All Clinique formulas are designed to deliver powerful efficacy with rigorous safety —clinically proven, allergy tested, and 100% fragrance free.

 

*Source: Circana, U.S. Prestige Beauty Total Measured Market, Skincare Unit Sales, Derm Brand Attribute, 12 Months Ending December 2023

**Source: Circana, U.S. Prestige Beauty Total Measured Market, Makeup Unit Sales, Derm Brand Attribute, 12 Months Ending December 2023

 

Derm Brand is defined as a brand that was founded or developed by a dermatologist and/or is dermatologist recommended.

 

Contacts:

Icahn Mount Sinai Contact: Laura Ruocco-Duran: Laura.Ruocco-Duran@mountsinai.org

Clinique Contact: Dorota Sekulska: DSekulsk@clinique.com

END


[Attachments] See images for this press release:
Clinique partners with Icahn School of Medicine at Mount Sinai to establish the Mount Sinai-Clinique Healthy Skin Dermatology Center

ELSE PRESS RELEASES FROM THIS DATE:

Strategies for enhancing the performance of nickel single-atom catalysts for the electroreduction of CO2 to CO

Strategies for enhancing the performance of nickel single-atom catalysts for the electroreduction of CO2 to CO
2024-02-02
Electrocatalytic reduction of carbon dioxide (CO2) is considered as an effective strategy for mitigating the energy crisis and the greenhouse effect. Among the multiple reduction products, CO is regarded as having the highest market value as it is a crucial feedstock for Fischer-Tropsch process which can synthesize high-value long-chain hydrocarbons. Since the carbon dioxide reduction reaction (CO2RR) has complex intermediates and multiple proton-coupled electron transfer processes, improving the reaction activity and products selectivity remain two great challenges. Single-atom catalysts (SACs) have the advantages of high atom utilization, tunable coordination structure ...

Brexit-induced spatial restrictions reveal alarming increase of fishing fleet’s carbon footprint

Brexit-induced spatial restrictions reveal alarming increase of fishing fleet’s carbon footprint
2024-02-02
In a study published today in Marine Policy, researchers have unveiled striking evidence that fisheries management decisions such as spatial fisheries restrictions can increase greenhouse gas emissions. The study, conducted by a team of scientists led by postdoctoral researcher Kim Scherrer at the University of Bergen, sheds light on the unforeseen consequences of policy changes on fishing fleets and their carbon footprint. In the North Atlantic, international agreements often allow fleets to follow the fish across national borders. This allows fishers to catch the fish where it is most efficient. But when the UK left the EU (Brexit), ...

Scammed! Animals ‘led by the nose’ to leave plants alone

Scammed! Animals ‘led by the nose’ to leave plants alone
2024-02-02
University of Sydney researchers have shown it is possible to shield plants from the hungry maws of herbivorous mammals by fooling them with the smell of a variety they typically avoid. Findings from the study published in Nature Ecology & Evolution show tree seedlings planted next to the decoy smell solution were 20 times less likely to be eaten by animals. “This is equivalent to the seedlings being surrounded by actual plants that are unpalatable to the herbivore. In most cases it does trick the animals into leaving the plants alone,” said PhD student Patrick ...

Why are people climate change deniers?

Why are people climate change deniers?
2024-02-02
Do climate change deniers bend the facts to avoid having to modify their environmentally harmful behavior? Researchers from the University of Bonn and the Institute of Labor Economics (IZA) ran an online experiment involving 4,000 US adults, and found no evidence to support this idea. The authors of the study were themselves surprised by the results. Whether they are good or bad news for the fight against global heating remains to be seen. The study is being published in the journal Nature Climate Change. STRICTLY EMBARGOED: Do not publish before Friday, February 02, 11 a.m. CET! A surprisingly large number of people ...

Epigenetic status determines metastasis

2024-02-02
Scientists from the German Cancer Research Center (DKFZ) and Heidelberg University investigated in mice how spreading tumor cells behave at the site of metastasis: Some tumor cells immediately start to form metastases. Others leave the blood vessel and may then enter a long period of dormancy. What determines which path the cancer cells take is their epigenetic status. This was also confirmed in experiments with human tumor cells. The results of the study could pave the way for novel diagnostic and therapeutic applications. What makes cancer so dangerous? ...

Prehistoric mobility among Tibetan farmers, herders shaped highland settlement patterns, cultural interaction, study finds

Prehistoric mobility among Tibetan farmers, herders shaped highland settlement patterns, cultural interaction, study finds
2024-02-02
The 1 million-square-mile Tibetan Plateau — often called the “roof of the world” — is the highest landmass in the world, averaging 14,000 feet in altitude. Despite the extreme environment, humans have been permanent inhabitants there since prehistoric times. Farming and herding play major roles in the economy of the Tibetan Plateau today — as they have throughout history. To make the most of a difficult environment, farmers, agropastoralists and mobile herders interact and move in conjunction with one another, which in turn shapes ...

World Wetlands Day: Bogs hold an important key to the climate crisis

2024-02-02
World Wetlands Day: Bogs hold an important key to the climate crisis Peat bogs store twice as much CO2 as all of the world's forests combined. A new research center at the University of Copenhagen will map Earth’s wetlands and provide important knowledge about the greenhouse gas budgets of these areas. The Global Wetland Center will teach us how to contain carbon from plants and trees in bogs and other wetlands – and preserve it as well as the ancient bog bodies also found there. He is world-renowned ...

Natural therapy shows promise for dry-eye disease

2024-02-02
Researchers at the University of Auckland are running a trial of castor oil as a potential safe and natural treatment for dry-eye disease following a successful pilot study. While exact figures aren’t available for New Zealand, in Australia, it is estimated dry-eye disease affects around 58 percent of the population aged over 50. Advancing age, menopause, increased screen time, contact lens wear are just some of the risk factors for developing dry eye disease. Blepharitis is the most common cause of dry-eye disease, accounting for more than 80 percent of cases. It is a chronic condition with no known cure. “Currently, patients ...

Researchers study role of post-transcriptional splicing in plant response to light

2024-02-02
In a study recently published in the PNAS on Jan. 30, a research team led by Prof. CAO Xiaofeng from the Institute of Genetics and Developmental Biology of the Chinese Academy of Sciences, in collaboration with researchers from the Southern University of Science and Technology, reported a new understanding of how light affects plant growth. Light plays a central role in plant growth and development, providing an energy source and governing various aspects of plant morphology. Post-transcriptional splicing (PTS) has been previously discovered to generate polyadenylated full-length transcripts. These transcripts, ...

Gene-editing offers hope for people with hereditary disorder

2024-02-02
A group of patients with a hereditary disorder have had their lives transformed by a single treatment of a breakthrough gene-editing therapy, according to the lead researcher. The patients from New Zealand, the Netherlands and the UK have hereditary angioedema, a genetic disorder characterised by severe, painful and unpredictable swelling attacks. These interfere with daily life and can affect airways and prove fatal. Now researchers from the University of Auckland, Amsterdam University Medical Center and Cambridge University Hospitals have successfully treated more than ten patients with the CRISPR/Cas9 therapy, ...

LAST 30 PRESS RELEASES:

Sexual health symptoms may correlate with poor adherence to adjuvant endocrine therapy in Black women with breast cancer

Black patients with triple-negative breast cancer may be less likely to receive immunotherapy than white patients

Affordable care act may increase access to colon cancer care for underserved groups

UK study shows there is less stigma against LGBTQ people than you might think, but people with mental health problems continue to experience higher levels of stigma

Bringing lost proteins back home

Better than blood tests? Nanoparticle potential found for assessing kidneys

Texas A&M and partner USAging awarded 2024 Immunization Neighborhood Champion Award

UTEP establishes collaboration with DoD, NSA to help enhance U.S. semiconductor workforce

Study finds family members are most common perpetrators of infant and child homicides in the U.S.

Researchers secure funds to create a digital mental health tool for Spanish-speaking Latino families

UAB startup Endomimetics receives $2.8 million Small Business Innovation Research grant

Scientists turn to human skeletons to explore origins of horseback riding

UCF receives prestigious Keck Foundation Award to advance spintronics technology

Cleveland Clinic study shows bariatric surgery outperforms GLP-1 diabetes drugs for kidney protection

Study reveals large ocean heat storage efficiency during the last deglaciation

Fever drives enhanced activity, mitochondrial damage in immune cells

A two-dose schedule could make HIV vaccines more effective

Wastewater monitoring can detect foodborne illness, researchers find

Kowalski, Salonvaara receive ASHRAE Distinguished Service Awards

SkAI launched to further explore universe

SLU researchers identify sex-based differences in immune responses against tumors

Evolved in the lab, found in nature: uncovering hidden pH sensing abilities

Unlocking the potential of patient-derived organoids for personalized sarcoma treatment

New drug molecule could lead to new treatments for Parkinson’s disease in younger patients

Deforestation in the Amazon is driven more by domestic demand than by the export market

Demand-side actions could help construction sector deliver on net-zero targets

Research team discovers molecular mechanism for a bacterial infection

What role does a tailwind play in cycling’s ‘Everesting’?

Projections of extreme temperature–related deaths in the US

Wearable device–based intervention for promoting patient physical activity after lung cancer surgery

[Press-News.org] Clinique partners with Icahn School of Medicine at Mount Sinai to establish the Mount Sinai-Clinique Healthy Skin Dermatology Center
New research center aims to deliver breakthrough advancements in dermatology and discover solutions for healthy and allergic skin